Retreatment of Recurrent Dupuytren's Contractures

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Dupuytren's Disease
Interventions
BIOLOGICAL

Collagenase clostridium histolyticum

up to three 0.58 mg injections

Trial Locations (13)

3145

Emeritus Research, Malvern East

4021

Peninsula Private Hospital, Kippa-Ring

4075

AusTrials Sherwood, Sherwood

10021

East River Professional Building, New York

16507

Hand Microsurgery and Reconstructive Orthopaedics, Erie

46260

The Indiana Hand to Shoulder Center, Indianapolis

49855

Marquette General Health System, Marquette

61107

Rockford Orthopedic Associates, Rockford

73109

Health Reserarch Institute, Oklahoma City

85050

HOPE Research Institute, Phoenix

SE-751

Uppsala Akademiska University Hospital, Uppsala

DE22 3NE

Pulvertaft Hand Center, Derby

NE1 4LP

Newcastle Upon Tyne Hospitals, Newcastle

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY